Evidence mapPaperPMID 41808245Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2026

Assessment of early-phase [

Robin Gröger, Amelie L Englert, Manvir Lalia, Lis de Weerd, Matteo Rovere, Lea Kunze, Giovanna Palumbo, Karin Wind-Mark, Sonja Fixemer, Sebastian N Roemer-Cassiano and 7 more

Abstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Robin GrögerDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Amelie L EnglertDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Manvir LaliaDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Lis de WeerdGerman Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
Matteo RovereDivision of Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Lea KunzeDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0003-4669-2113
Giovanna PalumboDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Karin Wind-MarkDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Sonja FixemerGerman Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
Sebastian N Roemer-CassianoInstitute for Stroke and Dementia Research (ISD), LMU Hospital, LMU Munich, Munich, Germany.ORCID 0000-0003-3423-457X
Nicolai FranzmeierInstitute for Stroke and Dementia Research (ISD), LMU Hospital, LMU Munich, Munich, Germany.
Günter HöglingerGerman Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
Andreas ZwergalDepartment of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.
Sabina TahirovicGerman Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
Rudolf A WernerDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Matthias BrendelDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0002-9247-2843
Johannes GnörichDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0003-1554-7765

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[

Indexed as

Alzheimer DiseaseAniline CompoundsBrainPositron-Emission TomographyStilbenesAmyloid beta-Protein PrecursorAnimalsDisease Models, AnimalFemaleFluorodeoxyglucose F18GlucoseMaleMiceMice, TransgenicRadiopharmaceuticals4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbeneAmyloid beta-Protein PrecursorAniline CompoundsFluorodeoxyglucose F18GlucoseRadiopharmaceuticalsStilbenesAlzheimer’s diseaseearly-phase β-amyloid PETFDG PETmouseperfusion

Identifiers

PMID41808245
PMCPMC12979222

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.